<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1244" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1244/" /><meta name="ncbi_pagename" content="Classic Ehlers-Danlos Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Classic Ehlers-Danlos Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Classic Ehlers-Danlos Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/07/26" /><meta name="citation_author" content="Fransiska Malfait" /><meta name="citation_author" content="Richard Wenstrup" /><meta name="citation_author" content="Anne De Paepe" /><meta name="citation_pmid" content="20301422" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1244/" /><meta name="citation_keywords" content="Ehlers-Danlos Syndrome, Classic Type" /><meta name="citation_keywords" content="EDS, Classic Type" /><meta name="citation_keywords" content="EDS Classic Type" /><meta name="citation_keywords" content="Ehlers-Danlos Syndrome, Classic Type" /><meta name="citation_keywords" content="Ehlers-Danlos Syndrome, Classic Type, COL5A1-Related" /><meta name="citation_keywords" content="Ehlers-Danlos Syndrome, Classic Type, COL5A2-Related" /><meta name="citation_keywords" content="Collagen alpha-1(I) chain" /><meta name="citation_keywords" content="Collagen alpha-1(V) chain" /><meta name="citation_keywords" content="Collagen alpha-2(V) chain" /><meta name="citation_keywords" content="COL1A1" /><meta name="citation_keywords" content="COL5A1" /><meta name="citation_keywords" content="COL5A2" /><meta name="citation_keywords" content="Classic Ehlers-Danlos Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Classic Ehlers-Danlos Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Fransiska Malfait" /><meta name="DC.Contributor" content="Richard Wenstrup" /><meta name="DC.Contributor" content="Anne De Paepe" /><meta name="DC.Date" content="2018/07/26" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1244/" /><meta name="description" content="Classic Ehlers-Danlos syndrome (cEDS) is a connective tissue disorder characterized by skin hyperextensibility, atrophic scarring, and generalized joint hypermobility (GJH). The skin is soft and doughy to the touch, and hyperextensible, extending easily and snapping back after release (unlike lax, redundant skin, as in cutis laxa). The skin is fragile, as manifested by splitting of the dermis following relatively minor trauma, especially over pressure points (knees, elbows) and areas prone to trauma (shins, forehead, chin). Wound healing is poor, and stretching of scars after apparently successful primary wound healing is characteristic. Complications of joint hypermobility, such as dislocations of the shoulder, patella, digits, hip, radius, and clavicle, usually resolve spontaneously or are easily managed by the affected individual. Other features include hypotonia with delayed motor development, fatigue and muscle cramps, and easy bruising. Mitral valve prolapse can occur infrequently, but tends to be of little clinical consequence. Aortic root dilatation has been reported, appears to be more common in young individuals, and rarely progresses." /><meta name="og:title" content="Classic Ehlers-Danlos Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="Classic Ehlers-Danlos syndrome (cEDS) is a connective tissue disorder characterized by skin hyperextensibility, atrophic scarring, and generalized joint hypermobility (GJH). The skin is soft and doughy to the touch, and hyperextensible, extending easily and snapping back after release (unlike lax, redundant skin, as in cutis laxa). The skin is fragile, as manifested by splitting of the dermis following relatively minor trauma, especially over pressure points (knees, elbows) and areas prone to trauma (shins, forehead, chin). Wound healing is poor, and stretching of scars after apparently successful primary wound healing is characteristic. Complications of joint hypermobility, such as dislocations of the shoulder, patella, digits, hip, radius, and clavicle, usually resolve spontaneously or are easily managed by the affected individual. Other features include hypotonia with delayed motor development, fatigue and muscle cramps, and easy bruising. Mitral valve prolapse can occur infrequently, but tends to be of little clinical consequence. Aortic root dilatation has been reported, appears to be more common in young individuals, and rarely progresses." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1244/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/eds/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1244/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE891338DFC8C601000000000347019A.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1244_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1244_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/ctlm/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/galactosemia/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1244_"><span class="title" itemprop="name">Classic Ehlers-Danlos Syndrome</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Ehlers-Danlos Syndrome, Classic Type; EDS, Classic Type</div><p class="contrib-group"><span itemprop="author">Fransiska Malfait</span>, MD, PhD, <span itemprop="author">Richard Wenstrup</span>, MD, and <span itemprop="author">Anne De Paepe</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1244_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1244_ai__"><div class="contrib half_rhythm"><span itemprop="author">Fransiska Malfait</span>, MD, PhD<div class="affiliation small">Center for Medical Genetics<br />Ghent University Hospital<br />Ghent, Belgium<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="eb.tnegu@tiaflam.aksisnarf" class="oemail">eb.tnegu@tiaflam.aksisnarf</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Richard Wenstrup</span>, MD<div class="affiliation small">Division of Human Genetics<br />Cincinnati Children's Hospital Medical Center<br />Cincinnati, Ohio<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.cmhcc@purtsnew.drahcir" class="oemail">gro.cmhcc@purtsnew.drahcir</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Anne De Paepe</span>, MD, PhD<div class="affiliation small">Center for Medical Genetics<br />Ghent University Hospital<br />Ghent, Belgium<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="eb.tnegu@epeaped.enna" class="oemail">eb.tnegu@epeaped.enna</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">May 29, 2007</span>; Last Update: <span itemprop="dateModified">July 26, 2018</span>.</p><p><em>Estimated reading time: 22 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="eds.Summary" itemprop="description"><h2 id="_eds_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Classic Ehlers-Danlos syndrome (cEDS) is a connective tissue disorder characterized by skin hyperextensibility, atrophic scarring, and generalized joint hypermobility (GJH). The skin is soft and doughy to the touch, and hyperextensible, extending easily and snapping back after release (unlike lax, redundant skin, as in cutis laxa). The skin is fragile, as manifested by splitting of the dermis following relatively minor trauma, especially over pressure points (knees, elbows) and areas prone to trauma (shins, forehead, chin). Wound healing is poor, and stretching of scars after apparently successful primary wound healing is characteristic. Complications of joint hypermobility, such as dislocations of the shoulder, patella, digits, hip, radius, and clavicle, usually resolve spontaneously or are easily managed by the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual. Other features include hypotonia with delayed motor development, fatigue and muscle cramps, and easy bruising. Mitral valve prolapse can occur infrequently, but tends to be of little clinical consequence. Aortic root dilatation has been reported, appears to be more common in young individuals, and rarely progresses.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of cEDS is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with the minimal clinical diagnostic criteria (skin hyperextensibility and atrophic scarring and either GJH or &#x02265;3 minor clinical criteria) and identification on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>COL5A1</i>, <i>COL5A2</i>, or (less commonly) <i>COL1A1</i>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Children with hypotonia and delayed motor development benefit from physiotherapy. Non-weight-bearing exercise promotes muscle strength and coordination. Anti-inflammatory drugs may alleviate joint pain. Those with hypotonia, joint instability, and chronic pain may need to adapt lifestyles accordingly. Dermal wounds are closed without tension, preferably in two layers. For other wounds, deep stitches are applied generously; cutaneous stitches are left in place twice as long as usual; and the borders of adjacent skin are carefully taped to prevent stretching of the scar. DDAVP<sup>&#x000ae;</sup> (deamino-delta-D-arginine vasopressin) may be useful to normalize bleeding time. Cardiovascular problems are treated in a standard manner.</p><p><i>Prevention of primary manifestations:</i> Young children with skin fragility can wear pads or bandages over the forehead, knees, and shins to avoid skin tears. Older children can wear soccer pads or ski stockings with shin padding during activities. Ascorbic acid (vitamin C) may reduce bruising.</p><p><i>Surveillance:</i> Yearly echocardiogram when aortic dilatation and/or mitral valve prolapse are present.</p><p><i>Agents/circumstances to avoid:</i> Sports with heavy joint strain; acetylsalicylate (aspirin).</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Classic EDS is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. It is estimated that approximately 50% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have an affected parent, and approximately 50% of affected individuals have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Each child of an affected individual has a 50% chance of inheriting the pathogenic variant. Once the pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="eds.Diagnosis"><h2 id="_eds_Diagnosis_">Diagnosis</h2><div id="eds.Suggestive_Findings"><h3>Suggestive Findings</h3><p>The diagnosis of classic Ehlers-Danlos syndrome (cEDS) can be suspected based on clinical examination and family history. Diagnostic criteria were developed by a medical advisory group in a conference at Villefranche in 1997 [<a class="bk_pop" href="#eds.REF.beighton.1998.31">Beighton et al 1998</a>] (<a href="http://onlinelibrary.wiley.com/doi/10.1002/%28SICI%291096-8628%2819980428%2977:1%3C31::AID-AJMG8%3E3.0.CO;2-O/pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">full text</a>; pdf) and recently revised by the International EDS Consortium [<a class="bk_pop" href="#eds.REF.malfait.2017.8">Malfait et al 2017</a>].</p><ul><li class="half_rhythm"><div>A <a href="#eds.Major_Diagnostic_Criteria_for_cEDS">major criterion</a> has high diagnostic specificity because it is present in the vast majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and/or it is characteristic for the disorder and allows differentiation from other EDS subtypes and/or other heritable connective tissue disorders.</div></li><li class="half_rhythm"><div>A <a href="#eds.Minor_Diagnostic_Criteria_for_cEDS">minor criterion</a> is a sign of lesser diagnostic specificity, but its presence supports the diagnosis.</div></li></ul><div id="eds.Major_Diagnostic_Criteria_for_cEDS"><h4>Major Diagnostic Criteria for cEDS</h4><p><b>Skin hyperextensibility.</b> See <a class="figpopup" href="/books/NBK1244/figure/eds.F1/?report=objectonly" target="object" rid-figpopup="figedsF1" rid-ob="figobedsF1">Figure 1</a>.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figedsF1" co-legend-rid="figlgndedsF1"><a href="/books/NBK1244/figure/eds.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figedsF1" rid-ob="figobedsF1"><img class="small-thumb" src="/books/NBK1244/bin/eds-Image001.gif" src-large="/books/NBK1244/bin/eds-Image001.jpg" alt="Figure 1. " /></a><div class="icnblk_cntnt" id="figlgndedsF1"><h4 id="eds.F1"><a href="/books/NBK1244/figure/eds.F1/?report=objectonly" target="object" rid-ob="figobedsF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Skin hyperextensibility </p></div></div><ul><li class="half_rhythm"><div>Skin hyperextensibility should be measured by pinching and lifting the cutaneous and subcutaneous layers of the skin on the volar surface at the middle of the non-dominant forearm as described by <a class="bk_pop" href="#eds.REF.remvig.2009.227">Remvig et al [2009]</a>.</div></li><li class="half_rhythm"><div>Skin is hyperextensible if it can be stretched over a standardized cutoff in three of the following areas: 1.5 cm for the distal part of the forearms and the dorsum of the hands; 3 cm for neck, elbows, and knees.</div></li></ul><p><b>Atrophic scarring</b>. See <a class="figpopup" href="/books/NBK1244/figure/eds.F2/?report=objectonly" target="object" rid-figpopup="figedsF2" rid-ob="figobedsF2">Figure 2</a>.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figedsF2" co-legend-rid="figlgndedsF2"><a href="/books/NBK1244/figure/eds.F2/?report=objectonly" target="object" title="Figure 2. " class="img_link icnblk_img figpopup" rid-figpopup="figedsF2" rid-ob="figobedsF2"><img class="small-thumb" src="/books/NBK1244/bin/eds-Image002.gif" src-large="/books/NBK1244/bin/eds-Image002.jpg" alt="Figure 2. " /></a><div class="icnblk_cntnt" id="figlgndedsF2"><h4 id="eds.F2"><a href="/books/NBK1244/figure/eds.F2/?report=objectonly" target="object" rid-ob="figobedsF2">Figure 2. </a></h4><p class="float-caption no_bottom_margin">Widened atrophic scars </p></div></div><p><b>Generalized joint hypermobility (GJH).</b> Joint hypermobility (see <a class="figpopup" href="/books/NBK1244/figure/eds.F3/?report=objectonly" target="object" rid-figpopup="figedsF3" rid-ob="figobedsF3">Figure 3</a>) depends on age, gender, and family and ethnic background.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figedsF3" co-legend-rid="figlgndedsF3"><a href="/books/NBK1244/figure/eds.F3/?report=objectonly" target="object" title="Figure 3. " class="img_link icnblk_img figpopup" rid-figpopup="figedsF3" rid-ob="figobedsF3"><img class="small-thumb" src="/books/NBK1244/bin/eds-Image003.gif" src-large="/books/NBK1244/bin/eds-Image003.jpg" alt="Figure 3. " /></a><div class="icnblk_cntnt" id="figlgndedsF3"><h4 id="eds.F3"><a href="/books/NBK1244/figure/eds.F3/?report=objectonly" target="object" rid-ob="figobedsF3">Figure 3. </a></h4><p class="float-caption no_bottom_margin">Passive flexion of thumbs to the forearm: manifestation of joint hypermobility </p></div></div><ul><li class="half_rhythm"><div>Joint hypermobility in cEDS is general, affecting both large and small joints, and is usually noted when a child starts to walk.</div></li><li class="half_rhythm"><div>It should be assessed using the Beighton scale, the most widely accepted grading system for the objective semi-quantification of joint hypermobility (see <a class="figpopup" href="/books/NBK1244/table/eds.T.beighton_criteria_for_joint_hyperm/?report=objectonly" target="object" rid-figpopup="figedsTbeightoncriteriaforjointhyperm" rid-ob="figobedsTbeightoncriteriaforjointhyperm">Table 1</a>).</div></li><li class="half_rhythm"><div>Since laxity decreases with age, individuals with a Beighton score of &#x0003c;5 may be considered positive based on historical observations (see <b>Five-point questionnaire</b>).</div></li></ul><div id="eds.T.beighton_criteria_for_joint_hyperm" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Beighton Criteria for Joint Hypermobility</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1244/table/eds.T.beighton_criteria_for_joint_hyperm/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__eds.T.beighton_criteria_for_joint_hyperm_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_eds.T.beighton_criteria_for_joint_hyperm_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Joint/Finding</th><th id="hd_h_eds.T.beighton_criteria_for_joint_hyperm_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Negative</th><th id="hd_h_eds.T.beighton_criteria_for_joint_hyperm_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unilateral</th><th id="hd_h_eds.T.beighton_criteria_for_joint_hyperm_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Bilateral</th></tr></thead><tbody><tr><td headers="hd_h_eds.T.beighton_criteria_for_joint_hyperm_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Passive dorsiflexion of the 5th finger &#x0003e;90&#x000b0;</td><td headers="hd_h_eds.T.beighton_criteria_for_joint_hyperm_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_eds.T.beighton_criteria_for_joint_hyperm_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_eds.T.beighton_criteria_for_joint_hyperm_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</td></tr><tr><td headers="hd_h_eds.T.beighton_criteria_for_joint_hyperm_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Passive flexion of thumbs to the forearm</td><td headers="hd_h_eds.T.beighton_criteria_for_joint_hyperm_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_eds.T.beighton_criteria_for_joint_hyperm_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_eds.T.beighton_criteria_for_joint_hyperm_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</td></tr><tr><td headers="hd_h_eds.T.beighton_criteria_for_joint_hyperm_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hyperextension of the elbows beyond 10&#x000b0;</td><td headers="hd_h_eds.T.beighton_criteria_for_joint_hyperm_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_eds.T.beighton_criteria_for_joint_hyperm_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_eds.T.beighton_criteria_for_joint_hyperm_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</td></tr><tr><td headers="hd_h_eds.T.beighton_criteria_for_joint_hyperm_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hyperextension of the knees beyond 10&#x000b0;</td><td headers="hd_h_eds.T.beighton_criteria_for_joint_hyperm_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_eds.T.beighton_criteria_for_joint_hyperm_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_eds.T.beighton_criteria_for_joint_hyperm_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</td></tr><tr><td headers="hd_h_eds.T.beighton_criteria_for_joint_hyperm_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Forward flexion of the trunk with knees fully extended and palms resting on the floor</td><td headers="hd_h_eds.T.beighton_criteria_for_joint_hyperm_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_eds.T.beighton_criteria_for_joint_hyperm_1_1_1_3 hd_h_eds.T.beighton_criteria_for_joint_hyperm_1_1_1_4" colspan="2" rowspan="1" style="text-align:left;vertical-align:middle;">1</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">A total score of &#x02265;5 defines hypermobility.</p></div></dd></dl></div></div></div><p><b>Five-point questionnaire</b> (adapted from <a class="bk_pop" href="#eds.REF.hakim.2003.163">Hakim &#x00026; Grahame [2003]</a>)</p><dl class="temp-labeled-list"><dt>1.</dt><dd><p class="no_top_margin">Can you now (or could you ever) place your hands flat on the floor without bending your knees?</p></dd><dt>2.</dt><dd><p class="no_top_margin">Can you now (or could you ever) bend your thumb to touch your forearm?</p></dd><dt>3.</dt><dd><p class="no_top_margin">As a child, did you amuse your friends by contorting your body into strange shapes or could you do the splits?</p></dd><dt>4.</dt><dd><p class="no_top_margin">As a child or teenager, did your shoulder or kneecap dislocate on more than one occasion?</p></dd><dt>5.</dt><dd><p class="no_top_margin">Do you consider yourself "double-jointed?"</p></dd></dl><p>Note: A "yes" answer to &#x02265;2 questions suggests joint hypermobility with 80%-85% <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> and 80%-90% specificity.</p></div><div id="eds.Minor_Diagnostic_Criteria_for_cEDS"><h4>Minor Diagnostic Criteria for cEDS</h4><ul><li class="half_rhythm"><div>Easy bruising</div></li><li class="half_rhythm"><div>Soft, doughy skin</div></li><li class="half_rhythm"><div>Skin fragility (or traumatic splitting)</div></li><li class="half_rhythm"><div>Molluscoid pseudotumors: fleshy, heaped-up lesions associated with scars over pressure points such as the elbows and knees</div></li><li class="half_rhythm"><div>Subcutaneous spheroids: small spherical hard bodies, frequently mobile, and palpable on the forearms and shins. Spheroids may be calcified and detectable radiologically.</div></li><li class="half_rhythm"><div>Hernia (or history thereof)</div></li><li class="half_rhythm"><div>Epicanthal folds</div></li><li class="half_rhythm"><div>Complications of joint hypermobility (e.g., sprains, dislocations/subluxations, pain, flexible flat foot)</div></li><li class="half_rhythm"><div>Family history of a <a class="def" href="/books/n/gene/glossary/def-item/first-degree-relative/">first-degree relative</a> who meets clinical criteria</div></li></ul><p>Classic Ehlers-Danlos syndrome (cEDS) <b>should be suspected</b> in individuals with both of the following:</p><ul><li class="half_rhythm"><div><a href="#eds.Major_Diagnostic_Criteria_for_cEDS">Major criteria</a> skin hyperextensibility and atrophic scarring</div></li><li class="half_rhythm"><div><a href="#eds.Major_Diagnostic_Criteria_for_cEDS">Major criterion</a> GJH and/or &#x02265;3 <a href="#eds.Minor_Diagnostic_Criteria_for_cEDS">minor criteria</a></div></li></ul></div></div><div id="eds.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of classic EDS <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with the minimal clinical diagnostic criteria and identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in one of the genes listed in <a class="figpopup" href="/books/NBK1244/table/eds.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figedsTmoleculargenetictestingusedin" rid-ob="figobedsTmoleculargenetictestingusedin">Table 3</a>.</p><p>Molecular genetic testing approaches can include <b>concurrent (or serial) single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Concurrent single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>COL5A1</i>, <i>COL5A2</i>, and <i>COL1A1</i> is performed first, followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div><div class="half_rhythm">Note: If serial <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> analysis is to be performed, <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>COL5A1</i> is performed first, followed by sequence analysis of <i>COL5A2</i> and then gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found. If the causative variant is not identified, <i>COL1A1</i> sequencing should be considered.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>COL5A1</i>, <i>COL5A2</i>, <i>COL1A1</i>, and other genes of interest (see <a href="#eds.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <b><a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a></b> and <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> may be considered. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> or genes that results in a similar clinical presentation).</div><div class="half_rhythm">For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div><div class="half_rhythm">Note: When a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be found, a type V collagen abnormality can sometimes be demonstrated by the <i>COL5A1</i> <a class="def" href="/books/n/gene/glossary/def-item/null/">null</a> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> test. The individual being tested must be <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a polymorphic marker in <i>COL5A1</i>; <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> from a skin biopsy is then tested to look for the presence of one or both markers. If one marker is not expressed, that allele is assumed to be nonfunctional (i.e., "null"). This type of testing is not widely available.</div></li></ul><div id="eds.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Classic Ehlers-Danlos Syndrome (cEDS)</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1244/table/eds.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__eds.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_eds.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_eds.T.molecular_genetic_testing_used_in_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1,&#x000a0;2</sup></th><th id="hd_h_eds.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_eds.T.molecular_genetic_testing_used_in_1_1_1_2" style="text-align:left;vertical-align:middle;">Proportion of cEDS Attributed to Pathogenic Variants in This Gene</th><th id="hd_h_eds.T.molecular_genetic_testing_used_in_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>3</sup> Detectable by Method</th></tr><tr><th headers="hd_h_eds.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_eds.T.molecular_genetic_testing_used_in_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>4</sup></th><th headers="hd_h_eds.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_eds.T.molecular_genetic_testing_used_in_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></th></tr></thead><tbody><tr><td headers="hd_h_eds.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COL1A1</i></td><td headers="hd_h_eds.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%&#x000a0;<sup>6</sup></td><td headers="hd_h_eds.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_eds.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%&#x000a0;<sup>6</sup></td><td headers="hd_h_eds.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_eds.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None reported&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_eds.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COL5A1</i></td><td headers="hd_h_eds.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">75%-78%&#x000a0;<sup>7</sup></td><td headers="hd_h_eds.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_eds.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">99%&#x000a0;<sup>7</sup></td><td headers="hd_h_eds.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_eds.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1%&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_eds.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COL5A2</i></td><td headers="hd_h_eds.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">14%&#x000a0;<sup>7</sup></td><td headers="hd_h_eds.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_eds.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%&#x000a0;<sup>7</sup></td><td headers="hd_h_eds.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_eds.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>8</sup></td></tr><tr><td headers="hd_h_eds.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_eds.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;10%&#x000a0;<sup>7</sup></td><td headers="hd_h_eds.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_eds.T.molecular_genetic_testing_used_in_1_1_2_1 hd_h_eds.T.molecular_genetic_testing_used_in_1_1_2_2" colspan="2" rowspan="1" style="text-align:left;vertical-align:middle;">NA</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="eds.TF.3.1"><p class="no_margin">Genes are listed in alphabetic order.</p></div></dd><dt>2. </dt><dd><div id="eds.TF.3.2"><p class="no_margin">See <a href="/books/NBK1244/#eds.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>3. </dt><dd><div id="eds.TF.3.3"><p class="no_margin">See <a href="#eds.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>4. </dt><dd><div id="eds.TF.3.4"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>5. </dt><dd><div id="eds.TF.3.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="eds.TF.3.6"><p class="no_margin"><a class="bk_pop" href="#eds.REF.brady.2017.70">Brady et al [2017]</a>, <a class="bk_pop" href="#eds.REF.malfait.2017.8">Malfait et al [2017]</a></p></div></dd><dt>7. </dt><dd><div id="eds.TF.3.7"><p class="no_margin"><a class="bk_pop" href="#eds.REF.symoens.2012.1485">Symoens et al [2012]</a>, <a class="bk_pop" href="#eds.REF.ritelli.2013.58">Ritelli et al [2013]</a></p></div></dd><dt>8. </dt><dd><div id="eds.TF.3.8"><p class="no_margin">No data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available.</p></div></dd></dl></div></div></div><p>Note: If genetic testing is not available, transmission electron microscopy (TEM) findings of collagen flowers on skin biopsy can support the clinical diagnosis, although not confirm it.</p></div></div><div id="eds.Clinical_Characteristics"><h2 id="_eds_Clinical_Characteristics_">Clinical Characteristics</h2><div id="eds.Clinical_Description"><h3>Clinical Description</h3><p>Classic Ehlers-Danlos syndrome (cEDS) is a connective tissue disorder characterized by skin hyperextensibility, abnormal wound healing, and generalized joint hypermobility. Previously, two subtypes, EDS type I and EDS type II, differing only in phenotypic severity, were recognized; it is now apparent that they form a continuum of clinical findings.</p><div id="eds.Skin"><h4>Skin</h4><p>Cutaneous hyperextensibility is one of the cardinal features of EDS in general and of cEDS in particular. Skin extends easily and snaps back after release (unlike lax, redundant skin, as in cutis laxa).</p><p>The skin is soft and doughy to the touch.</p><p>The skin is fragile, as manifested by splitting of the dermis following relatively minor trauma, especially over pressure points (knees, elbows) and areas prone to trauma (shins, forehead, chin). Skin fragility may cause dehiscence of sutured incisions in skin or mucosa.</p><p>Wound healing is poor, and stretching of scars after apparently successful primary wound healing is characteristic. Scars become wide, with a "cigarette-paper"-like (papyraceous) appearance.</p><p>Other dermatologic features in cEDS:</p><ul><li class="half_rhythm"><div>Molluscoid pseudotumors</div></li><li class="half_rhythm"><div>Subcutaneous spheroids</div></li><li class="half_rhythm"><div>Piezogenic papules: small, painful, reversible herniations of underlying adipose tissue globules through the fascia into the dermis, such as on medial and lateral aspects of the feet upon standing</div></li><li class="half_rhythm"><div>Elastosis perforans serpiginosa: a rare skin condition of unknown etiology characterized by skin-colored to erythematous keratotic papules, some enlarging outwards in serpiginous or arcuate configurations, leaving slightly atrophic centers</div></li><li class="half_rhythm"><div>Acrocyanosis: a painless disorder caused by constriction or narrowing of the small blood vessels in the skin (affecting mainly the hands) in which the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> areas turn blue and become cold and sweaty; localized swelling may also occur</div></li><li class="half_rhythm"><div>Chilblains: cold injuries, characterized by a red swollen skin that is tender and hot to the touch, and may itch; can develop in less than two hours in skin exposed to cold</div></li></ul></div><div id="eds.Tissue_Fragility"><h4>Tissue Fragility</h4><p>Manifestations of generalized tissue extensibility and fragility are observed in multiple organs:</p><ul><li class="half_rhythm"><div>Cervical insufficiency during pregnancy</div></li><li class="half_rhythm"><div>Inguinal and umbilical hernia</div></li><li class="half_rhythm"><div>Hiatal and incisional hernia</div></li><li class="half_rhythm"><div>Recurrent rectal prolapse in early childhood</div></li></ul></div><div id="eds.Joints"><h4>Joints</h4><p>Complications of joint hypermobility including dislocations of the shoulder, patella, digits, hip, radius, and clavicle may occur and usually resolve spontaneously or are easily managed by the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual. Some individuals with cEDS may experience chronic joint and limb pain, despite normal skeletal radiographs.</p><p>Other problems related to the joint hypermobility are joint instability, foot deformities such as <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> clubfoot or <i>pes planus</i>, temporomandibular joint dysfunction, joint effusions, and osteoarthritis [<a class="bk_pop" href="#eds.REF.hagberg.2004.178">Hagberg et al 2004</a>, <a class="bk_pop" href="#eds.REF.de_coster.2005a.298">De Coster et al 2005a</a>, <a class="bk_pop" href="#eds.REF.de_coster.2005b.47">De Coster et al 2005b</a>].</p></div><div id="eds.Neurologic_Features"><h4>Neurologic Features</h4><p>Primary muscular hypotonia may occur and may cause delayed motor development, problems with ambulation, and mild motor disturbance in individuals with cEDS. Fatigue and muscle cramps are relatively frequent. Rarely, CSF leak has been reported to cause postural hypotension and headache [<a class="bk_pop" href="#eds.REF.schievink.2004.65">Schievink et al 2004</a>].</p></div><div id="eds.Easy_Bruising"><h4>Easy Bruising</h4><p>Easy bruising is a common finding and manifests as spontaneous ecchymoses, frequently recurring in the same areas and causing a characteristic brownish discoloration of the skin, especially in exposed areas such as shins and knees. There is a tendency toward prolonged bleeding (e.g., following brushing of the teeth) in spite of a normal coagulation status.</p></div><div id="eds.Cardiovascular"><h4>Cardiovascular</h4><p>Structural cardiac malformations are uncommon in cEDS.</p><p>Mitral valve prolapse and (less frequently) tricuspid valve prolapse may occur. Stringent criteria should be used for the diagnosis of mitral valve prolapse. When it does occur, mitral valve prolapse tends to be of little clinical consequence [<a class="bk_pop" href="#eds.REF.atzinger.2011.826">Atzinger et al 2011</a>].</p><p>Aortic root dilatation has been reported in cEDS [<a class="bk_pop" href="#eds.REF.wenstrup.2002.112">Wenstrup et al 2002</a>, <a class="bk_pop" href="#eds.REF.mcdonnell.2006.129">McDonnell et al 2006</a>, <a class="bk_pop" href="#eds.REF.atzinger.2011.826">Atzinger et al 2011</a>]. It appears to be more common in young individuals and rarely progresses [<a class="bk_pop" href="#eds.REF.atzinger.2011.826">Atzinger et al 2011</a>].</p><p>Spontaneous rupture of large arteries, along with intracranial aneurysms and arteriovenous fistulae, may occur in the rare individual with a severe form of cEDS.</p></div><div id="eds.Pregnancy"><h4>Pregnancy</h4><p>Pregnancy in a woman with cEDS places both the newborn and the mother at risk for complications (see <a href="#eds.Pregnancy_Management">Pregnancy Management</a>). As a whole, the complications are more frequent than in the normal population, although it is difficult to quantitate the incidence of each complication in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals because no good studies exist.</p><ul><li class="half_rhythm"><div>Preterm rupture of the membranes and prematurity can occur when the mother is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, and also when the fetus is affected, especially in the most severe forms.</div></li><li class="half_rhythm"><div>Because of hypotonia, breech presentation is more frequent if the baby is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and may lead to dislocation of the hips or shoulder of the newborn.</div></li></ul></div></div><div id="eds.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>/<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlations have emerged to date.</p><p>Although numbers are still limited, pathogenic variants in <i>COL5A2</i> are thought to result in a <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> at the more severe end of the classic EDS spectrum.</p></div><div id="eds.Penetrance"><h3>Penetrance</h3><p>It is unknown whether <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> is 100% or reduced. It is presumed to be the same for males and females.</p></div><div id="eds.Nomenclature"><h3>Nomenclature</h3><p>As a result of the 1997 Villefranche conference on EDS [<a class="bk_pop" href="#eds.REF.beighton.1998.31">Beighton et al 1998</a>], the former EDS type I and type II were reclassified as EDS, classic type. In 2017, the International EDS Consortium proposed a revised EDS classification system. The new nomenclature for EDS, classic type is classic EDS, or cEDS [<a class="bk_pop" href="#eds.REF.malfait.2017.8">Malfait et al 2017</a>].</p></div><div id="eds.Prevalence"><h3>Prevalence</h3><p>The prevalence of cEDS has been estimated at 1:20,000 [<a class="bk_pop" href="#eds.REF.byers.2001">Byers 2001</a>]. However, it is likely that some individuals with milder manifestations of the disease, previously classified as EDS type II, do not come to medical attention and thus go undetected.</p></div></div><div id="eds.Genetically_Related_Allelic_Disorder"><h2 id="_eds_Genetically_Related_Allelic_Disorder_">Genetically Related (Allelic) Disorders</h2><p>No other phenotypes are associated with pathogenic variants in <i>COL5A1</i> or <i>COL5A2</i>.</p><p>The majority of pathogenic variants in <i>COL1A1</i> are associated with <a href="/books/n/gene/oi/">osteogenesis imperfecta</a> (OI). Rarely, specific pathogenic variants in <i>COL1A1</i> are associated with arthrochalasia EDS (OMIM <a href="https://omim.org/entry/130060" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">130060</a>), EDS/OI overlap phenotypes [<a class="bk_pop" href="#eds.REF.cabral.2005.19259">Cabral et al 2005</a>], or <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> infantile cortical hyperostosis (<a href="/books/n/gene/caffey/">Caffey disease</a>).</p></div><div id="eds.Differential_Diagnosis"><h2 id="_eds_Differential_Diagnosis_">Differential Diagnosis</h2><p>Other forms of Ehlers-Danlos syndrome (EDS) should be considered in individuals with easy bruising, joint hypermobility, and/or chronic joint dislocation. Clinical overlap is seen with all other forms of EDS, in particular with the following subtypes.</p><div id="eds.T.other_eds_disorders_to_consider_in" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Other EDS disorders to Consider in the Differential Diagnosis of Classic EDS</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1244/table/eds.T.other_eds_disorders_to_consider_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__eds.T.other_eds_disorders_to_consider_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Clinical Features of This Disorder</th></tr><tr><th headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_4" id="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping w/cEDS</th><th headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_4" id="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing from cEDS</th></tr></thead><tbody><tr><td headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Classic-like EDS<br />(OMIM <a href="https://omim.org/entry/606408" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">606408</a>)</td><td headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TNXB</i></td><td headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_4 hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Skin hyperextensibility</div></li><li class="half_rhythm"><div>Velvety skin</div></li><li class="half_rhythm"><div>GJH</div></li><li class="half_rhythm"><div>Easy bruising</div></li></ul>
</td><td headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_4 hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>AR inheritance</div></li><li class="half_rhythm"><div>Absence of atrophic scarring</div></li></ul>
</td></tr><tr><td headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cardiac-valvular EDS<br />(OMIM <a href="https://omim.org/entry/225320" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">225320</a>)</td><td headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COL1A2</i></td><td headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_4 hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Skin hyperextensibility</div></li><li class="half_rhythm"><div>Atrophic scarring</div></li><li class="half_rhythm"><div>Easy bruising</div></li><li class="half_rhythm"><div>(Generalized) joint hypermobility</div></li></ul>
</td><td headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_4 hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>AR inheritance</div></li><li class="half_rhythm"><div>Severe progressive cardiac-valvular problems</div></li></ul>
</td></tr><tr><td headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/eds3/">Hypermobile EDS</a></td><td headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_4 hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>GJH</div></li><li class="half_rhythm"><div>Soft, velvety skin</div></li><li class="half_rhythm"><div>Mild skin hyperextensibility</div></li><li class="half_rhythm"><div>Mild atrophic scarring</div></li></ul>
</td><td headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_4 hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Absence of truly papyraceous &#x00026;/or hemosiderotic scars</td></tr><tr><td headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Arthrochalasia EDS<br />(OMIM <a href="https://omim.org/entry/130060" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">130060</a>, <a href="https://omim.org/entry/617821" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">617821</a>)</td><td headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COL1A1</i><br /><i>COL1A2</i></td><td headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_4 hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>GJH</div></li><li class="half_rhythm"><div>Skin hyperextensibility</div></li><li class="half_rhythm"><div>Atrophic scarring</div></li><li class="half_rhythm"><div>Easy bruising</div></li></ul>
</td><td headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_4 hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Bilateral <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> hip dislocation</td></tr><tr><td headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dermatosparaxis EDS<br />(OMIM <a href="https://omim.org/entry/225410" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">225410</a>)</td><td headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ADAMTS2</i></td><td headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_4 hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Soft, doughy skin texture</div></li><li class="half_rhythm"><div>Atrophic scarring</div></li><li class="half_rhythm"><div>Skin hyperextensibility</div></li><li class="half_rhythm"><div>GJH</div></li></ul>
</td><td headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_4 hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Extreme skin fragility (usually &#x0003e; than in cEDS)</div></li><li class="half_rhythm"><div>Redundant, almost lax, skin</div></li><li class="half_rhythm"><div>Unusual craniofacial features</div></li><li class="half_rhythm"><div>Postnatal growth restriction</div></li><li class="half_rhythm"><div>AR inheritance</div></li></ul>
</td></tr><tr><td headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/eds6/">Kyphoscoliotic EDS</a></td><td headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PLOD1</i></td><td headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_4 hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>GJH</div></li><li class="half_rhythm"><div>Skin hyperextensibility</div></li><li class="half_rhythm"><div>Easy bruising</div></li><li class="half_rhythm"><div>Atrophic scarring</div></li></ul>
</td><td headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_4 hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Congenital muscle hypotonia</td></tr><tr><td headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/fkbp14-keds/">Kyphoscoliotic EDS w/myopathy &#x00026; neurosensory hearing loss</a></td><td headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FKBP14</i></td><td headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_4 hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>GJH</div></li><li class="half_rhythm"><div>Skin hyperextensibility</div></li><li class="half_rhythm"><div>Easy bruising</div></li></ul>
</td><td headers="hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_1_4 hd_h_eds.T.other_eds_disorders_to_consider_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Congenital muscle hypotonia</div></li><li class="half_rhythm"><div>Muscle atrophy</div></li><li class="half_rhythm"><div>Congenital hearing impairment</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; GJH = generalized joint hypermobility; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a></p></div></dd></dl></div></div></div></div><div id="eds.Management"><h2 id="_eds_Management_">Management</h2><p>For a detailed review of complications and management, see <a class="bk_pop" href="#eds.REF.bowen.2017.27">Bowen et al [2017]</a>.</p><div id="eds.Evaluations_Following_Initial_Diagno"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease in an individual diagnosed with classic Ehlers-Danlos syndrome (cEDS), the following evaluations are recommended if they have not already been completed:</p><ul><li class="half_rhythm"><div>Clinical examination of the skin with assessment of skin hyperextensibility, atrophic scars and bruises, and other manifestations of cEDS</div></li><li class="half_rhythm"><div>Evaluation of joint mobility with use of the Beighton score</div></li><li class="half_rhythm"><div>Evaluation for hypotonia and motor development in infants and children</div></li><li class="half_rhythm"><div>A baseline echocardiogram with aortic diameter measurement at diagnosis</div></li><li class="half_rhythm"><div>Evaluation of clotting factors if severe easy bruising is present</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="eds.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>In children with hypotonia and delayed motor development, a physiotherapeutic program is important.</p><p>Non-weight-bearing muscular exercise, such as swimming, is useful to promote muscular development and coordination.</p><p>Individuals with muscle hypotonia and joint instability with chronic pain may have to adjust lifestyle and professional choices accordingly. Emotional support and behavioral and psychological therapy may help in developing acceptance and coping skills.</p><p>Dermal wounds should be closed without tension, preferably in two layers. Deep stitches should be applied generously. Cutaneous stitches should be left in place twice as long as usual and additional fixation of adjacent skin with adhesive tape can help prevent stretching of the scar.</p><p>DDAVP<sup>&#x000ae;</sup> (deamino-delta-D-arginine vasopressin) may be useful to normalize bleeding time. It may be beneficial in case of bruising or epistaxis, or before procedures such as dental extractions.</p><p>For recommendations on treatment of joint laxity and dislocations, see <a href="/books/n/gene/eds3/">Hypermobile EDS</a>. (Note: Surgical stabilization of joints may lead to disappointing, or only temporary, improvement.)</p><p>Anti-inflammatory drugs may help with joint pain.</p><p>Long-term chronic pain may result in the need for mental health services.</p><p>Cardiovascular problems should be treated in a standard manner.</p></div><div id="eds.Prevention_of_Primary_Manifestations"><h3>Prevention of Primary Manifestations</h3><p>Very young children with pronounced skin fragility can wear protective pads or bandages over the forehead, knees, and shins in order to avoid skin tears. Older children who are active can wear soccer pads or ski stockings with shin padding during activities. Contact sports should be avoided.</p><p>For recommendations on prevention of primary manifestations of joint laxity and dislocations, see <a href="/books/n/gene/eds3/#eds3.Management">Hypermobile EDS: Management</a>: <b>Prevention of Primary Manifestations</b>.</p><p>Ascorbic acid (vitamin C) may reduce easy bruising but has no effect on the primary findings of skin hyperextensibility, atrophic scarring, and joint hypermobility. In general, a dose of two grams per day is recommended for adults, with proportionally reduced doses for children; however, there is no limitation.</p></div><div id="eds.Prevention_of_Secondary_Complication"><h3>Prevention of Secondary Complications</h3><p>For recommendations on prevention of secondary manifestations of joint laxity and dislocations, see <a href="/books/n/gene/eds3/#eds3.Management">Hypermobile EDS: Management</a>: <b>Prevention of Secondary Complications</b>.</p></div><div id="eds.Surveillance"><h3>Surveillance</h3><p>If no abnormalities are found on echocardiogram in an adult, a follow-up echocardiogram is not necessary. (Because longitudinal data on progression of aortic dilation are not available, specific recommendations for follow up in individuals with a normal aortic diameter are not available.)</p><p>If no abnormalities are found on echocardiogram in a child, follow up directed by the pediatric cardiologist is recommended.</p><p>Yearly echocardiogram is warranted if an abnormality such as aortic dilatation or mitral valve prolapse is present.</p></div><div id="eds.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>The following should be avoided:</p><ul><li class="half_rhythm"><div>Sports with heavy joint strain (contact sports, fighting sports, football, running)</div></li><li class="half_rhythm"><div>Acetylsalicylate (aspirin)</div></li></ul></div><div id="eds.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to clarify the genetic status of apparently asymptomatic older and younger at-risk relatives of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family in order to identify as early as possible those who would benefit from prompt initiation of treatment and preventive measures.</p><p>See <a href="#eds.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="eds.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Because of the increased risk for skin lacerations, postpartum hemorrhages, and prolapse of the uterus and/or bladder, monitoring of women throughout pregnancy and in the postpartum period is recommended.</p><p>Ascorbic acid (vitamin C) may reduce easy bruising (see <a href="#eds.Prevention_of_Primary_Manifestations">Prevention of Primary Manifestations</a>); in general, 2 g/day is recommended for adults; however, no strict guidelines exist regarding recommended dose during the third trimester of pregnancy.</p><p>Monitoring of pregnant women for preterm labor is warranted during the third trimester when the risk for premature rupture of the membranes is increased.</p></div><div id="eds.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="eds.Genetic_Counseling"><h2 id="_eds_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="eds.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Classic Ehlers-Danlos syndrome (cEDS) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="eds.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>It is estimated that 50% of individuals diagnosed with cEDS have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>It is estimated that 50% of individuals diagnosed with cEDS have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>The parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> should be evaluated by physical examination of the skin with special attention to delayed wound healing, easy bruising, joint hypermobility or recurrent dislocations, and chronic articular pain.</div></li><li class="half_rhythm"><div>Molecular genetic testing is recommended for the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent. Though theoretically possible, no instances of germline mosaicism have been reported.</div></li><li class="half_rhythm"><div>The family history of some individuals diagnosed with cEDS may appear to be negative because of failure to recognize the disorder in family members or, theoretically, reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> (it is unknown whether penetrance is 100% or reduced). Therefore, an apparently negative family history cannot be confirmed unless appropriate clinical evaluation and/or <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> has been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the clinical/genetic status of the proband's parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>/known to have the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in the proband, the risk to the sibs is 50%. Intrafamilial phenotypic variability is observed.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is estimated at 1% because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#eds.REF.rahbari.2016.126">Rahbari et al 2016</a>].</div></li><li class="half_rhythm"><div>If the parents have not been tested for the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> but are clinically unaffected, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> appears to be low.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with classic EDS has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Intrafamilial phenotypic variability is observed.</p><p><b>Other family members</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members may be at risk.</p></div><div id="eds.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#eds.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>At-risk individuals.</b> The severity, specific symptoms, and progression of the disorder are variable and cannot be predicted based on family history or results of <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i>. However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="eds.Prenatal_Testing_and_Preimplantation"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="eds.Resources"><h2 id="_eds_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Association Francaise des Syndrome d'Ehlers Danlos (AFSED)</b></div><div>67, rue Jules Lecesne</div><div>Le Havre 76600</div><div>France</div><div><b>Phone:</b> 0820 20 37 33</div><div><b>Email:</b> contact@afsed.com</div><div><a href="http://afsed.fr/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.afsed.fr</a></div></li><li class="half_rhythm"><div><b>Ehlers-Danlos Society - Europe</b></div><div>35-37 Ludgate Hill</div><div>Office 7</div><div>London EC4M 7JN</div><div>United Kingdom</div><div><b>Phone:</b> +44 203 887 6132</div></li><li class="half_rhythm"><div><b>Ehlers-Danlos Society Headquarters</b></div><div>P.O. Box 87463</div><div>Montgomery Village MD 20886</div><div><b>Phone:</b> 410-670-7577</div><div><b>Email:</b> info@ehlers-danlos.com</div><div><a href="https://ehlers-danlos.com/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ehlers-danlos.com</a></div></li><li class="half_rhythm"><div><b>Ehlers-Danlos Support Group</b></div><div>PO Box 337</div><div>Aldershot Surrey GU12 6WZ</div><div>United Kingdom</div><div><b>Phone:</b> 01252 690940</div><div><b>Email:</b> director@ehlers-danlos.org</div><div><a href="http://www.ehlers-danlos.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ehlers-danlos.org</a></div></li><li class="half_rhythm"><div><b>Ehlers-Danlos Support UK</b></div><div>PO Box 748</div><div>Borehamwood WD6 9HU</div><div>United Kingdom</div><div><b>Phone:</b> 0208 736 5604; 0800 9078518</div><div><a href="https://www.ehlers-danlos.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ehlers-danlos.org</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=ehlersdanlossyndrome" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Ehlers-Danlos syndrome</a></div></li><li class="half_rhythm"><div><b>Medline Plus</b></div><div><a href="http://www.nlm.nih.gov/medlineplus/ehlersdanlossyndrome.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Ehlers-Danlos Syndrome</a></div></li><li class="half_rhythm"><div><b>Ehlers-Danlos Society EDS &#x00026; Related Disorders Global Registry</b></div><div><a href="https://www.ehlers-danlos.com/eds-global-registry/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ehlers-danlos.com/eds-global-registry</a></div></li></ul></div><div id="eds.Molecular_Genetics"><h2 id="_eds_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="eds.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Classic Ehlers-Danlos Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1244/table/eds.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__eds.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_eds.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_eds.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_eds.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_eds.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_eds.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_eds.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_eds.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1277" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>COL1A1</i></a></td><td headers="hd_b_eds.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1277" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">17q21<wbr style="display:inline-block"></wbr>​.33</a></td><td headers="hd_b_eds.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P02452" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Collagen alpha-1(I) chain</a></td><td headers="hd_b_eds.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://oi.gene.le.ac.uk/home.php?select_db=COL1A1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Osteogenesis Imperfecta Mutation Database - COL1A1</a></td><td headers="hd_b_eds.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=COL1A1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COL1A1</a></td><td headers="hd_b_eds.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=COL1A1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COL1A1</a></td></tr><tr><td headers="hd_b_eds.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1289" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>COL5A1</i></a></td><td headers="hd_b_eds.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1289" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">9q34<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_eds.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P20908" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Collagen alpha-1(V) chain</a></td><td headers="hd_b_eds.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://eds.gene.le.ac.uk/home.php?select_db=COL5A1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Ehlers-Danlos Syndrome Variant Database (COL5A1)</a></td><td headers="hd_b_eds.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=COL5A1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COL5A1</a></td><td headers="hd_b_eds.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=COL5A1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COL5A1</a></td></tr><tr><td headers="hd_b_eds.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1290" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>COL5A2</i></a></td><td headers="hd_b_eds.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1290" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">2q32<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_eds.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P05997" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Collagen alpha-2(V) chain</a></td><td headers="hd_b_eds.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://eds.gene.le.ac.uk/home.php?select_db=COL5A2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Ehlers-Danlos Syndrome Variant Database (COL5A2)</a></td><td headers="hd_b_eds.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=COL5A2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COL5A2</a></td><td headers="hd_b_eds.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=COL5A2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COL5A2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="eds.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="eds.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Classic Ehlers-Danlos Syndrome (<a href="/omim/120150,120190,120215,130000" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1244/table/eds.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__eds.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/120150" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">120150</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">COLLAGEN, TYPE I, ALPHA-1; COL1A1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/120190" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">120190</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">COLLAGEN, TYPE V, ALPHA-2; COL5A2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/120215" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">120215</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">COLLAGEN, TYPE V, ALPHA-1; COL5A1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/130000" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">130000</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1; EDSCL1</td></tr></tbody></table></div></div><p><b><i>COL1A1</i></b></p><p><b>Gene structure.</b>
<i>COL1A1</i> is 18 kilobases in size and is composed of 52 exons (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000088.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000088.3</a>).</p><p><b>Pathogenic variants.</b> Although most pathogenic variants in <i>COL1A1</i> cause osteogenesis imperfecta, specific <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants have been associated with specific EDS subtypes. In particular, <a class="bk_pop" href="#eds.REF.nuytinck.2000.1398">Nuytinck et al [2000]</a> reported two children with classic EDS with a c.934C&#x0003e;T (p.Arg312Cys) <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. <a class="bk_pop" href="#eds.REF.malfait.2007.387">Malfait et al [2007]</a> identified the same variant in an adult with signs of cEDS, who suffered from a rupture of medium-sized arteries. This pathogenic variant was subsequently found in two other adults with EDS and complications of vascular fragility [<a class="bk_pop" href="#eds.REF.ritelli.2013.58">Ritelli et al 2013</a>, <a class="bk_pop" href="#eds.REF.gaines.2015.595.e11">Gaines et al 2015</a>].</p><div id="eds.T.col1a1_pathogenic_variants_discuss" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p><i>COL1A1</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1244/table/eds.T.col1a1_pathogenic_variants_discuss/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__eds.T.col1a1_pathogenic_variants_discuss_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_eds.T.col1a1_pathogenic_variants_discuss_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_eds.T.col1a1_pathogenic_variants_discuss_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_eds.T.col1a1_pathogenic_variants_discuss_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_eds.T.col1a1_pathogenic_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.934C&#x0003e;T</td><td headers="hd_h_eds.T.col1a1_pathogenic_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg312Cys</td><td headers="hd_h_eds.T.col1a1_pathogenic_variants_discuss_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000088.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000088<wbr style="display:inline-block"></wbr>​.3</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>COL1A1</i> encodes the 1,464-amino acid pro &#x003b1;1 chains of type I collagen, whose triple helix comprises two &#x003b1;1 chains and one &#x003b1;2 chain. Type I is a fibril-forming collagen found in most connective tissues and is abundant in bone, cornea, dermis, and tendon.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The pathogenetic basis for the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> resulting from this COL1A1 Arg-to-Cys substitution is currently not well understood. Ultrastructural studies of dermal collagen fibrils have shown fibrils with variable diameters, slightly irregular contour, and, in the case of p.Arg312Cys, flower-like abnormalities [<a class="bk_pop" href="#eds.REF.malfait.2007.387">Malfait et al 2007</a>].</p><p>Several mechanisms have been proposed as possibly involved in the pathogenesis including [<a class="bk_pop" href="#eds.REF.malfait.2007.387">Malfait et al 2007</a>]:</p><ul><li class="half_rhythm"><div>Local destabilization of the triple helix due to loss of the stabilizing arginine residue;</div></li><li class="half_rhythm"><div>Introduction of a cysteine residue, which can lead to disulfide bonding with other collagenous or non-collagenous proteins, either intracellularly or in the extracellular matrix (ECM), thereby disturbing normal physiologic interactions;</div></li><li class="half_rhythm"><div>Interference with pericellular processing of the amino-propeptide of procollagen type I; and/or</div></li><li class="half_rhythm"><div>Local unwinding of the region surrounding the mutations, thereby disturbing specific interactions with type I collagen ligands.</div></li></ul><p><b><i>COL5A1</i></b></p><p><b>Gene structure.</b> The <i>COL5A1</i> <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> comprises 66 exons distributed over more than 150 kb of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1244/#eds.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Several types of pathogenic variants have been identified in <i>COL5A1</i>:</p><ul><li class="half_rhythm"><div>The most common types of molecular defect lead to <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> for <i>COL5A1</i> <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a>. In approximately 40%-50% of individuals with cEDS, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> or frameshift variants are responsible for a nonfunctional <i>COL5A1</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> [<a class="bk_pop" href="#eds.REF.schwarze.2000.1757">Schwarze et al 2000</a>, <a class="bk_pop" href="#eds.REF.wenstrup.2000.1766">Wenstrup et al 2000</a>, <a class="bk_pop" href="#eds.REF.schwarze.2001.989">Schwarze et al 2001</a>, <a class="bk_pop" href="#eds.REF.malfait.2005.28">Malfait et al 2005</a>, <a class="bk_pop" href="#eds.REF.symoens.2012.1485">Symoens et al 2012</a>, <a class="bk_pop" href="#eds.REF.ritelli.2013.58">Ritelli et al 2013</a>]. The predicted consequence of haploinsufficiency is synthesis of approximately half the amount of normal type V collagen.</div></li><li class="half_rhythm"><div>In a small proportion of individuals, a <i>COL5A1</i> variant affects the structural integrity of type V collagen, resulting in the production of a functionally defective type V collagen protein (<a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> variant). These structural variants are most commonly <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants that result in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> skipping and a few single-nucleotide variants that result in the substitution for glycine in the triple-helical region of the collagen molecule.</div></li><li class="half_rhythm"><div>A unique <a class="def" href="/books/n/gene/glossary/def-item/single-nucleotide-variant/">single-nucleotide variant</a> in a highly conserved cysteine residue, p.Cys1639Ser, in the C-terminal propeptide of the &#x003b1;1(V) collagen chain has also been identified.</div></li><li class="half_rhythm"><div>In contrast to other collagen disorders, few pathogenic variants in glycine residues have been found. A p.Gly530Ser substitution in the amino-terminal propeptide of the &#x003b1;1(V) chain may be disease modifying when present in the <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> state and disease causing in the <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> state [<a class="bk_pop" href="#eds.REF.giunta.2000.72">Giunta &#x00026; Steinmann 2000</a>, <a class="bk_pop" href="#eds.REF.giunta.2002.284">Giunta et al 2002</a>].</div></li></ul><div id="eds.T.col5a1_pathogenic_variants_discuss" class="table"><h3><span class="label">Table 6. </span></h3><div class="caption"><p><i>COL5A1</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1244/table/eds.T.col5a1_pathogenic_variants_discuss/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__eds.T.col5a1_pathogenic_variants_discuss_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_eds.T.col5a1_pathogenic_variants_discuss_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_eds.T.col5a1_pathogenic_variants_discuss_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_eds.T.col5a1_pathogenic_variants_discuss_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_eds.T.col5a1_pathogenic_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1588G&#x0003e;A</td><td headers="hd_h_eds.T.col5a1_pathogenic_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly530Ser</td><td headers="hd_h_eds.T.col5a1_pathogenic_variants_discuss_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_000093.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000093<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_000084.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000084<wbr style="display:inline-block"></wbr>​.3</a></td></tr><tr><td headers="hd_h_eds.T.col5a1_pathogenic_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4916G&#x0003e;C</td><td headers="hd_h_eds.T.col5a1_pathogenic_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Cys1639Ser</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Collagen &#x003b1;1 (V) chain (type V collagen chains). Type V collagen is a quantitatively minor fibrillar collagen that is widely distributed in a variety of tissues. It is present mainly as [&#x003b1;1(V)]<sub>2</sub> &#x003b1;2(V) heterotrimers in skin, bone, and tendon. It forms heterotypic fibrils with type I collagen and regulates the diameter of those fibrils, presumably through its very large amino-terminal propeptide. Data indicate that type V collagen controls collagen fibril assembly in several tissues [<a class="bk_pop" href="#eds.REF.wenstrup.2004.53331">Wenstrup et al 2004</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Missense variants in the triple helical <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of the &#x003b1;1(V) or &#x003b1;2(V) chains are likely to have <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> activity; that is, the abnormal form can interfere with protein from the normal <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>. Diminished amounts, caused by premature termination of codons in <i>COL5A1</i> or <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> product, may alter normal collagen fibrillogenesis.</p><p><b><i>COL5A2</i></b></p><p><b>Gene structure.</b> The <i>COL5A2</i> <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> comprises 51 exons distributed over 67 kb. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1244/#eds.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Structural pathogenic variants in <i>COL5A2</i> have been demonstrated in few individuals with classic EDS. These structural variants are most commonly <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants that result in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> skipping [<a class="bk_pop" href="#eds.REF.michalickova.1998.249">Michalickova et al 1998</a>, <a class="bk_pop" href="#eds.REF.malfait.2005.28">Malfait et al 2005</a>, <a class="bk_pop" href="#eds.REF.symoens.2012.1485">Symoens at al 2012</a>] and a few nucleotide variants that result in substitution for glycine in the triple-helical region of the collagen molecule [<a class="bk_pop" href="#eds.REF.richards.1998.846">Richards et al 1998</a>, <a class="bk_pop" href="#eds.REF.symoens.2012.1485">Symoens et al 2012</a>, <a class="bk_pop" href="#eds.REF.ritelli.2013.58">Ritelli et al 2013</a>].</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Collagen &#x003b1;2(V) chains (type V collagen chains). Type V collagen is a quantitatively minor fibrillar collagen that is widely distributed in a variety of tissues. It is present mainly as [&#x003b1;1(V)]<sub>2</sub>, &#x003b1;2(V) heterotrimers in skin, bone, and tendon. It forms heterotypic fibrils with type I collagen and regulates the diameter of those fibrils, presumably through its very large amino-terminal propeptide.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Missense variants in the triple helical <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of the &#x003b1;1(V) or &#x003b1;2(V) chains are likely to have <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> activity; that is, the abnormal forms can interfere with protein derived from the normal <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>.</p></div><div id="eds.References"><h2 id="_eds_References_">References</h2><div id="eds.Published_Guidelines__Consensus_Stat"><h3>Published Guidelines / Consensus Statements</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="eds.REF.bowen.2017.27">Bowen JM, Sobey GJ, Burrows NP, Colombi M, Lavallee ME, Malfait F, Francomano CA. Ehlers-Danlos syndrome, classical type. <span><span class="ref-journal">Am J Med Genet C Semin Med Genet. </span>2017;<span class="ref-vol">175</span>:27–39.</span> [<a href="/pubmed/28192633" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28192633</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds.REF.malfait.2017.8">Malfait F, Francomano C, Byers P, Belmont J, Berglund B, Black J, Bloom L, Bowen JM, Brady AF, Burrows NP, Castori M, Cohen H, Colombi M, Demirdas S, De Backer J, De Paepe A, Fournel-Gigleux S, Frank M, Ghali N, Giunta C, Grahame R, Hakim A, Jeunemaitre X, Johnson D, Juul-Kristensen B, Kapferer-Seebacher I, Kazkaz H, Kosho T, Lavallee ME, Levy H, Mendoza-Londono R, Pepin M, Pope FM, Reinstein E, Robert L, Rohrbach M, Sanders L, Sobey GJ, Van Damme T, Vandersteen A, van Mourik C, Voermans N, Wheeldon N, Zschocke J, Tinkle B. The 2017 international classification of the Ehlers&#x02013;Danlos syndromes. <span><span class="ref-journal">Am J Med Genet C Semin Med Genet. </span>2017;<span class="ref-vol">175</span>:8–26.</span> [<a href="/pubmed/28306229" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28306229</span></a>]</div></li></ul></div><div id="eds.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="eds.REF.atzinger.2011.826">Atzinger CL, Meyer RA, Khoury PR, Gao Z, Tinkle BT. Cross-sectional and longitudinal assessment of aortic root dilation and valvular anomalies in hypermobile and classic Ehlers-Danlos syndrome. <span><span class="ref-journal">J Pediatr. </span>2011;<span class="ref-vol">158</span>:826–830.e1.</span> [<a href="/pubmed/21193204" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21193204</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds.REF.beighton.1998.31">Beighton P, De Paepe A, Steinmann B, Tsipouras P, Wenstrup RJ. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers- Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). <span><span class="ref-journal">Am J Med Genet. </span>1998;<span class="ref-vol">77</span>:31–7.</span> [<a href="/pubmed/9557891" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9557891</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds.REF.brady.2017.70">Brady AF, Demirdas S, Fournel-Gigleux S, Ghali N, Giunta C, Kapferer-Seebacher I, Kosho T, Mendoza-Londono R, Pope MF, Rohrbach M, Van Damme T, Vandersteen A, van Mourik C, Voermans N, Zschocke J, Malfait F. The Ehlers-Danlos syndromes, rare types. <span><span class="ref-journal">Am J Med Genet C Semin Med Genet. </span>2017;<span class="ref-vol">175</span>:70–115.</span> [<a href="/pubmed/28306225" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28306225</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds.REF.bowen.2017.27_1">Bowen JM, Sobey GJ, Burrows NP, Colombi M, Lavallee ME, Malfait F, Francomano CA. Ehlers-Danlos syndrome, classical type. <span><span class="ref-journal">Am J Med Genet C Semin Med Genet. </span>2017;<span class="ref-vol">175</span>:27–39.</span> [<a href="/pubmed/28192633" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28192633</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds.REF.byers.2001">Byers PH. Disorders of collagen biosynthesis and structure. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. <em>The Metabolic and Molecular Bases of Inherited Disease</em>. 2 ed. Edinburgh, UK: Churchill Livingstone; 2001:1065-81.</div></li><li class="half_rhythm"><div class="bk_ref" id="eds.REF.cabral.2005.19259">Cabral WA, Makareeva E, Colige A, Letocha AD, Ty JM, Yeowell HN, Pals G, Leikin S, Marini JC. Mutations near amino end of alpha-1(I) collagen cause combined osteogenesis imperfecta/Ehlers-Danlos syndrome by interference with N-propeptide processing. <span><span class="ref-journal">J Biol Chem. </span>2005;<span class="ref-vol">280</span>:19259–69.</span> [<a href="/pubmed/15728585" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15728585</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds.REF.de_coster.2005a.298">De Coster PJ, Martens LC, De Paepe A. Oral health in prevalent types of Ehlers-Danlos syndromes. <span><span class="ref-journal">J Oral Pathol Med. </span>2005a;<span class="ref-vol">34</span>:298–307.</span> [<a href="/pubmed/15817074" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15817074</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds.REF.de_coster.2005b.47">De Coster PJ, Van den Berghe LI, Martens LC. Generalized joint hypermobility and temporomandibular disorders: inherited connective tissue disease as a model with maximum expression. <span><span class="ref-journal">J Orofac Pain. </span>2005b;<span class="ref-vol">19</span>:47–57.</span> [<a href="/pubmed/15779539" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15779539</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds.REF.gaines.2015.595.e11">Gaines R, Tinkle BT, Halandras PM, Al-Nouri O, Crisostomo P, Cho JS. Spontaneous ruptured dissection of the right common iliac artery in a patient with classic Ehlers-Danlos syndrome phenotype. <span><span class="ref-journal">Ann Vasc Surg. </span>2015;<span class="ref-vol">29</span>:595.e11–4.</span> [<a href="/pubmed/25597651" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25597651</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds.REF.giunta.2002.284">Giunta C, Nuytinck L, Raghunath M, Hausser I, De Paepe A, Steinmann B. Homozygous Gly530Ser substitution in COL5A1 causes mild classical Ehlers-Danlos syndrome. <span><span class="ref-journal">Am J Med Genet. </span>2002;<span class="ref-vol">109</span>:284–90.</span> [<a href="/pubmed/11992482" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11992482</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds.REF.giunta.2000.72">Giunta C, Steinmann B. Compound heterozygosity for a disease-causing G1489E [correction of G1489D] and disease-modifying G530S substitution in COL5A1 of a patient with the classical type of Ehlers-Danlos syndrome: an explanation of intrafamilial variability? <span><span class="ref-journal">Am J Med Genet. </span>2000;<span class="ref-vol">90</span>:72–9.</span> [<a href="/pubmed/10602121" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10602121</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds.REF.hagberg.2004.178">Hagberg C, Berglund B, Korpe L, Andersson-Norinder J. Ehlers-Danlos Syndrome (EDS) focusing on oral symptoms: a questionnaire study. <span><span class="ref-journal">Orthod Craniofac Res. </span>2004;<span class="ref-vol">7</span>:178–85.</span> [<a href="/pubmed/15359504" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15359504</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds.REF.hakim.2003.163">Hakim AJ, Grahame R. A simple questionnaire to detect hypermobility: an adjunct to the assessment of patients with diffuse musculoskeletal pain. <span><span class="ref-journal">Int J Clin Pract. </span>2003;<span class="ref-vol">57</span>:163–6.</span> [<a href="/pubmed/12723715" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12723715</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds.REF.malfait.2005.28">Malfait F, Coucke P, Symoens S, Loeys B, Nuytinck L, De Paepe A. The molecular basis of classic Ehlers-Danlos syndrome: a comprehensive study of biochemical and molecular findings in 48 unrelated patients. <span><span class="ref-journal">Hum Mutat. </span>2005;<span class="ref-vol">25</span>:28–37.</span> [<a href="/pubmed/15580559" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15580559</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds.REF.malfait.2017.8_1">Malfait F, Francomano C, Byers P, Belmont J, Berglund B, Black J, Bloom L, Bowen JM, Brady AF, Burrows NP, Castori M, Cohen H, Colombi M, Demirdas S, De Backer J, De Paepe A, Fournel-Gigleux S, Frank M, Ghali N, Giunta C, Grahame R, Hakim A, Jeunemaitre X, Johnson D, Juul-Kristensen B, Kapferer-Seebacher I, Kazkaz H, Kosho T, Lavallee ME, Levy H, Mendoza-Londono R, Pepin M, Pope FM, Reinstein E, Robert L, Rohrbach M, Sanders L, Sobey GJ, Van Damme T, Vandersteen A, van Mourik C, Voermans N, Wheeldon N, Zschocke J, Tinkle B. The 2017 international classification of the Ehlers&#x02013;Danlos syndromes. <span><span class="ref-journal">Am J Med Genet C Semin Med Genet. </span>2017;<span class="ref-vol">175</span>:8–26.</span> [<a href="/pubmed/28306229" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28306229</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds.REF.malfait.2007.387">Malfait F, Symoens S, De Backer J, Hermanns-L&#x000ea; T, Sakalihasan N, Lapi&#x000e8;re CM, Coucke P, De Paepe A. Three arginine to cysteine substitutions in the pro-alpha (I)-collagen chain cause Ehlers-Danlos syndrome with a propensity to arterial rupture in early adulthood. <span><span class="ref-journal">Hum Mutat. </span>2007;<span class="ref-vol">28</span>:387–95.</span> [<a href="/pubmed/17211858" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17211858</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds.REF.mcdonnell.2006.129">McDonnell NB, Gorman BL, Mandel KW, Schurman SH, Assanah-Carroll A, Mayer SA, Najjar SS, Francomano CA. Echocardiographic findings in classical and hypermobile Ehlers-Danlos syndromes. <span><span class="ref-journal">Am J Med Genet A. </span>2006;<span class="ref-vol">140</span>:129–36.</span> [<a href="/pubmed/16353246" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16353246</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds.REF.michalickova.1998.249">Michalickova K, Susic M, Willing MC, Wenstrup RJ, Cole WG. Mutations of the alpha2(V) chain of type V collagen impair matrix assembly and produce Ehlers-Danlos syndrome type I. <span><span class="ref-journal">Hum Mol Genet. </span>1998;<span class="ref-vol">7</span>:249–55.</span> [<a href="/pubmed/9425231" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9425231</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds.REF.nuytinck.2000.1398">Nuytinck L, Freund M, Lagae L, Pierard GE, Hermanns-Le T, De Paepe A. Classical Ehlers-Danlos syndrome caused by a mutation in type I collagen. <span><span class="ref-journal">Am J Hum Genet. </span>2000;<span class="ref-vol">66</span>:1398–402.</span> [<a href="/pmc/articles/PMC1288203/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1288203</span></a>] [<a href="/pubmed/10739762" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10739762</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds.REF.rahbari.2016.126">Rahbari R, Wuster A, Lindsay SJ, Hardwick RJ, Alexandrov LB, Turki SA, Dominiczak A, Morris A, Porteous D, Smith B, Stratton MR, Hurles ME, et al.  Timing, rates and spectra of human germline mutation. <span><span class="ref-journal">Nat Genet. </span>2016;<span class="ref-vol">48</span>:126–33.</span> [<a href="/pmc/articles/PMC4731925/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4731925</span></a>] [<a href="/pubmed/26656846" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26656846</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds.REF.remvig.2009.227">Remvig L, Duhn PH, Ullman S, Kobayasi T, Hansen B, Juul-Kristensen B, Jurvelin JS, Arokoski J. Skin extensibility and consistency in patients with Ehlers-Danlos syndrome and benign joint hypermobility syndrome. <span><span class="ref-journal">Scand J Rheumatol. </span>2009;<span class="ref-vol">38</span>:227–30.</span> [<a href="/pubmed/19169910" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19169910</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds.REF.richards.1998.846">Richards AJ, Martin S, Nicholls AC, Harrison JB, Pope FM, Burrows NP. A single base mutation in COL5A2 causes Ehlers-Danlos syndrome type II. <span><span class="ref-journal">J Med Genet. </span>1998;<span class="ref-vol">35</span>:846–8.</span> [<a href="/pmc/articles/PMC1051462/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1051462</span></a>] [<a href="/pubmed/9783710" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9783710</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds.REF.ritelli.2013.58">Ritelli M, Dordoni C, Venturini M, Chiarelli N, Quinzani S, Traversa M, Zoppi N, Vascellaro A, Wischmeijer A, Manfredini E, Garavelli L, Calzavara-Pinton P, Colombi M. Clinical and molecular characterization of 40 patients with classic Ehlers-Danlos syndrome: identification of 18 COL5A1 and 2 COL5A2 novel mutations. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2013;<span class="ref-vol">8</span>:58.</span> [<a href="/pmc/articles/PMC3653713/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3653713</span></a>] [<a href="/pubmed/23587214" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23587214</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds.REF.schievink.2004.65">Schievink WI, Gordon OK, Tourje J. Connective tissue disorders with spontaneous spinal cerebrospinal fluid leaks and intracranial hypotension: a prospective study. <span><span class="ref-journal">Neurosurgery. </span>2004;<span class="ref-vol">54</span>:65–70.</span> [<a href="/pubmed/14683542" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14683542</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds.REF.schwarze.2000.1757">Schwarze U, Atkinson M, Hoffman GG, Greenspan DS, Byers PH. Null alleles of the COL5A1 gene of type V collagen are a cause of the classical forms of Ehlers-Danlos syndrome (types I and II). <span><span class="ref-journal">Am J Hum Genet. </span>2000;<span class="ref-vol">66</span>:1757–65.</span> [<a href="/pmc/articles/PMC1378060/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1378060</span></a>] [<a href="/pubmed/10796876" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10796876</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds.REF.schwarze.2001.989">Schwarze U, Schievink WI, Petty E, Jaff MR, Babovic-Vuksanovic D, Cherry KJ, Pepin M, Byers PH. Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV. <span><span class="ref-journal">Am J Hum Genet. </span>2001;<span class="ref-vol">69</span>:989–1001.</span> [<a href="/pmc/articles/PMC1274375/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1274375</span></a>] [<a href="/pubmed/11577371" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11577371</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds.REF.symoens.2012.1485">Symoens S, Syx D, Malfait F, Callewaert B, De Backer J, Vanakker O, Coucke P, De Paepe A. Comprehensive molecular analysis demonstrates type V collagen mutations in over 90% of patients with classic EDS and allows to refine diagnostic criteria. <span><span class="ref-journal">Hum Mutat. </span>2012;<span class="ref-vol">33</span>:1485–93.</span> [<a href="/pubmed/22696272" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22696272</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds.REF.wenstrup.2004.53331">Wenstrup RJ, Florer JB, Brunskill EW, Bell SM, Chervoneva I, Birk DE. Type V collagen controls the initiation of collagen fibril assembly. <span><span class="ref-journal">J Biol Chem. </span>2004;<span class="ref-vol">279</span>:53331–7.</span> [<a href="/pubmed/15383546" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15383546</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds.REF.wenstrup.2000.1766">Wenstrup RJ, Florer JB, Willing MC, Giunta C, Steinmann B, Young F, Susic M, Cole WG. COL5A1 haploinsufficiency is a common molecular mechanism underlying the classical form of EDS. <span><span class="ref-journal">Am J Hum Genet. </span>2000;<span class="ref-vol">66</span>:1766–76.</span> [<a href="/pmc/articles/PMC1378044/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1378044</span></a>] [<a href="/pubmed/10777716" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10777716</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds.REF.wenstrup.2002.112">Wenstrup RJ, Meyer RA, Lyle JS, Hoechstetter L, Rose PS, Levy HP, Francomano CA. Prevalence of aortic root dilation in the Ehlers-Danlos syndrome. <span><span class="ref-journal">Genet Med. </span>2002;<span class="ref-vol">4</span>:112–7.</span> [<a href="/pubmed/12180144" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12180144</span></a>]</div></li></ul></div></div><div id="eds.Chapter_Notes"><h2 id="_eds_Chapter_Notes_">Chapter Notes</h2><div id="eds.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>26 July 2018 (ha) Comprehensive update posted live</div></li><li class="half_rhythm"><div>18 August 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>11 May 2010 (cd) Revision: changes in testing</div></li><li class="half_rhythm"><div>24 July 2008 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>29 May 2007 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of entire <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a> available for <i>COL5A1</i> and <i>COL5A2</i> and prenatal testing available</div></li><li class="half_rhythm"><div>10 April 2006 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>29 October 2003 (ca) Review posted live</div></li><li class="half_rhythm"><div>20 June 2003 (rw, ad) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1244</span><span class="label">PMID: <a href="/pubmed/20301422" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301422</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/ctlm/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/galactosemia/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1244&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1244/?report=reader">PubReader</a></li><li><a href="/books/NBK1244/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1244" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1244" style="display:none" title="Cite this Page"><div class="bk_tt">Malfait F, Wenstrup R, De Paepe A. Classic Ehlers-Danlos Syndrome. 2007 May 29 [Updated 2018 Jul 26]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1244/pdf/Bookshelf_NBK1244.pdf">PDF version of this page</a> (326K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#eds.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#eds.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#eds.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#eds.Genetically_Related_Allelic_Disorder" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#eds.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#eds.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#eds.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#eds.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#eds.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#eds.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#eds.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1290[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">COL5A2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1289[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">COL5A1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK1244+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1462320" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1462320" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1462320" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1462320" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20847697" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Clinical and genetic aspects of Ehlers-Danlos syndrome, classic type.</a><span class="source">[Genet Med. 2010]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Clinical and genetic aspects of Ehlers-Danlos syndrome, classic type.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Malfait F, Wenstrup RJ, De Paepe A. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Genet Med. 2010 Oct; 12(10):597-605. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23587214" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Clinical and molecular characterization of 40 patients with classic Ehlers-Danlos syndrome: identification of 18 COL5A1 and 2 COL5A2 novel mutations.</a><span class="source">[Orphanet J Rare Dis. 2013]</span><div class="brieflinkpop offscreen_noflow">Clinical and molecular characterization of 40 patients with classic Ehlers-Danlos syndrome: identification of 18 COL5A1 and 2 COL5A2 novel mutations.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Ritelli M, Dordoni C, Venturini M, Chiarelli N, Quinzani S, Traversa M, Zoppi N, Vascellaro A, Wischmeijer A, Manfredini E, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Orphanet J Rare Dis. 2013 Apr 12; 8:58. Epub 2013 Apr 12.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301667" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Vascular Ehlers-Danlos Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Vascular Ehlers-Danlos Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Byers PH. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/16278879" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Molecular genetics in classic Ehlers-Danlos syndrome.</a><span class="source">[Am J Med Genet C Semin Med Gen...]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Molecular genetics in classic Ehlers-Danlos syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Malfait F, De Paepe A. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Med Genet C Semin Med Genet. 2005 Nov 15; 139C(1):17-23. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301510" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Marfan Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Marfan Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Dietz H. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301422" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301422" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc9307dde0891169a97b4a">Classic Ehlers-Danlos Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Classic Ehlers-Danlos Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T04:23:19-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal102&amp;ncbi_phid=CE891338DFC8C601000000000347019A&amp;ncbi_session=CE891338DFC93061_0839SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1244%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1244&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1244/&amp;ncbi_pagename=Classic Ehlers-Danlos Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE891338DFC93061_0839SID /projects/books/PBooks@5.22 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>